


ARTHEx Biotech Email Formats
Biotechnology Research • Paterna, Valencian Community, Spain • 21-50 Employees
ARTHEx Biotech Email Formats
ARTHEx Biotech uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@arthexbiotech.com), used 52.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@arthexbiotech.com | 52.6% |
{first name}{last name} | johndoe@arthexbiotech.com | 31.6% |
{last name}{last name} | doedoe@arthexbiotech.com | 10.5% |
{first initial}{second initial} | jo@arthexbiotech.com | 5.3% |
Key Contacts at ARTHEx Biotech
Beatriz Llamusi
Ceo And Co-Founder
Frederic Legros
Chief Executive Officer
Pedro Fernandez Nohales
Director Of Operations
Georgina Butler
Director Project Management
Company overview
| Headquarters | Catedrático Agustín Escardino, 9, Paterna, Valencia 46980, ES |
| Phone number | +34625016629 |
| Website | |
| NAICS | 541714 |
| Keywords | Health, Biotech, Biotecnología, Farma, Enfermedades Raras, Desarrollo De Fármacos, Oligonucleotidos Terapéuticos |
| Founded | 2019 |
| Employees | 21-50 |
| Socials |
About ARTHEx Biotech
ARTHEx Biotech is a spin-off biotech company from the University of Valencia (Spain) focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical needs. ARTHEx has developed its proprietary platform that allows fast and flexible development of investigational miR-modulating oligonucleotides that are designed to enter relevant tissues in pharmacological quantities, in order to treat diseases in which microRNAs play a key role. The first investigational product from this platform is ATX-01, an antimiR in development for Myotonic Dystrophy Type 1 (DM1). DM1 is an orphan disease affecting more than 900,000 people worldwide (estimated prevalence 1/8,000) with no cure, nor approved treatment to date. ATX-01 is a first-in-class disease-modifying therapy that addresses the cause of DM1 with a dual and unique mechanism of action, which targets micro-RNA-23b a key factor in the disease pathogenesis. To learn more about Arthex Biotech, please visit us at www.arthexbiotech.com
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
ARTHEx Biotech has 15 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore ARTHEx Biotech's funding history, including investment rounds, total capital raised, and key backers.
ARTHEx Biotech Tech Stack
Discover the technologies and tools that power ARTHEx Biotech's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Miscellaneous
Security
Widgets
Miscellaneous
JavaScript libraries
Page builders
Font scripts
Frequently asked questions
4.8
40,000 users



